Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Prostate. 2023 Feb 13;83(7):641–648. doi: 10.1002/pros.24497

Figure 1.

Figure 1.

Histomorphological and immunophenotypic characterization of amphicrine prostate cancers. Representative micrographs show H&E, synaptophysin (SYP) and NKX3.1 immunohistochemistry. Note the diffuse positivity for SYP and NKX3.1 in all cases. Scale bars denote 20 um.